This series is for clinicians, nurses, APPs to have a forum to discuss the management of complex lymphoma cases. During this we discuss appropriate management options, clinical trial availability, and recently published data that would guide our decision making. We review pathology, radiological images, and clinical course for each patient presented.
Key Words: Lymphoma, Treatment, Pathology, Leukemia
- Physicians
- Nurse Practitioners
- Physician Assistants
- Nurses
- Pharmacists
- Psychologists
- Social Workers
Participants who engage in this educational intervention will be able to:
- Manage various complex lymphoma cases
- Utilize diagnostic and pathological tools utilized to characterize a lymphoma
- Improve patient outcomes through group discussion
Planning Committee:
Nirav Shah, MD (Activity Director)
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Sumana Devata, MD
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Timothy Fenske, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Mehdi Hamadani, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Walter Longo, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Sumana Devata, MD
- Walter Longo, MD
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Name | Company | Role |
---|---|---|
Nirav Shah, MD | Loxo-Lilly | Consultant, Researcher |
Miltenyi Biotec | Consultant, Researcher | |
Epizyme | Advisory Board | |
Janssen | Advisory Board | |
Kite Pharma | Advisory Board | |
Incyte | Advisory Board | |
Seattle Genetics | Advisory Board | |
Novartis | Advisory Board | |
BMS-Juno | Advisory Board | |
TG Therapeutics | Advisory Board | |
Umoja | Advisory Board | |
Tundra Therapeutics | Advisory Board/Founder | |
Timothy Fenske, MD | AstraZeneca | Consultant/Speaker |
Kite Pharmaceuticals | Consultant/Speaker | |
Beigene | Consultant/Speaker | |
AbbVie | Consultant | |
Seagen | Consultant/Speaker | |
Adaptive Biotechnologies | Consultant | |
TG Therapeutics | Speaker | |
Lilly/Loxo | Consultant | |
ADC Therapeutics | Consultant | |
Ono Pharmaceuticals | Consultant | |
MorphoSys | Consultant/speaker | |
Mehdi Hamadani, MD | ADC Therapeutics | Consultant/Speaker/Researcher |
Spectrum Pharmaceuticals | Researcher | |
Astellas Pharma | Researcher | |
Omeros | Consultant | |
CRISPR | Consultant/speaker | |
BMS | Consultant | |
Kite Pharmaceuticals | Consultant/speaker | |
Abbvie | Consultant | |
Genmab | Consultant | |
Allovir | Consultant | |
Caribou | Consultant | |
AstraZeneca | Speaker | |
BeiGene | Speaker | |
Genentech | Speaker | |
Myeloid Therapeutics | Speaker |
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
-10 MOC points in the American Board of Pathology (ABPath) Maintenance of Certification (MOC) program; and
-10 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.